These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 12710864)
1. Cardiovascular drug therapy in the elderly: theoretical and practical considerations. Williams BR; Kim J Drugs Aging; 2003; 20(6):445-63. PubMed ID: 12710864 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular drug therapy in the elderly. Aronow WS; Frishman WH; Cheng-Lai A Cardiol Rev; 2007; 15(4):195-215. PubMed ID: 17575484 [TBL] [Abstract][Full Text] [Related]
3. Effects of cardiovascular disease on pharmacokinetics. Rodighiero V Cardiovasc Drugs Ther; 1989 Oct; 3(5):711-30. PubMed ID: 2577313 [TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450-mediated cardiovascular drug interactions. Scheen AJ Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1065-82. PubMed ID: 21810031 [TBL] [Abstract][Full Text] [Related]
6. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular pharmacotherapy in patients with Marfan syndrome. Yetman AT Am J Cardiovasc Drugs; 2007; 7(2):117-26. PubMed ID: 17503882 [TBL] [Abstract][Full Text] [Related]
8. Issues in the perioperative management of the elderly patient with cardiovascular disease. Sear JW; Higham H Drugs Aging; 2002; 19(6):429-51. PubMed ID: 12149050 [TBL] [Abstract][Full Text] [Related]
10. Gender, ethnicity, and genes in cardiovascular disease. Part 2: implications for pharmacotherapy. Schaefer BM; Caracciolo V; Frishman WH; Charney P Heart Dis; 2003; 5(3):202-14. PubMed ID: 12783634 [TBL] [Abstract][Full Text] [Related]
11. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916 [TBL] [Abstract][Full Text] [Related]
12. Sex and gender differences in cardiovascular drug therapy. Seeland U; Regitz-Zagrosek V Handb Exp Pharmacol; 2012; (214):211-36. PubMed ID: 23027453 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2. Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721 [TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics of vasodilators. Part I. Kirsten R; Nelson K; Kirsten D; Heintz B Clin Pharmacokinet; 1998 Jun; 34(6):457-82. PubMed ID: 9646008 [TBL] [Abstract][Full Text] [Related]
16. [Changes in parameters of coagulation system after treatment of chronic heart failure with β-adrenoblockers, angiotensin-converting enzyme inhibitors, calcium antagonists, diuretics, anticoagulants, antiagregants, cardiac glycosides, and physical exercise]. Mongirdienė A Medicina (Kaunas); 2011; 47(4):238-43. PubMed ID: 21829057 [TBL] [Abstract][Full Text] [Related]
17. The importance of circadian rhythms on drug response in hypertension and coronary heart disease--from mice and man. Lemmer B Pharmacol Ther; 2006 Sep; 111(3):629-51. PubMed ID: 16480770 [TBL] [Abstract][Full Text] [Related]
18. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs]. Noll G; Kaufmann U; Wenzel RR; Lüscher TF Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular pharmacotherapeutic considerations in patients undergoing anesthesia. Wolf A; McGoldrick KE Cardiol Rev; 2011; 19(1):12-6. PubMed ID: 21135597 [TBL] [Abstract][Full Text] [Related]